RxDoctor Payments DataLook up a doctor →

Timothy McCavit

Pediatric Hematology-Oncology · Fort Worth, TXNPI 1811959687

Payments from drug & device makers

$174,878in general payments, 2019–2025

Across 1,128 payments — averaging $155.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$65K
  • Sanofi$42K
  • American Regent$24K
  • Genentech, Inc.$16K
  • Genentech USA, Inc.$13K
  • Spark Therapeutics, Inc.$10K
  • plus $5K from 5 others

What the payments were for

  • Consulting fees$30,73456%
  • Speaking & faculty fees$19,55236%
  • Travel & lodging$2,8795%
  • Food & beverage$1,8773%

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$174,878 in reported general payments places this provider in the 80th percentile of 235 pediatric hematology-oncology providers in Texas.

See all pediatric hematology-oncology providers in Texas

Other pediatric hematology-oncology in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →